Advertisement
UK markets close in 5 hours 57 minutes
  • FTSE 100

    7,823.16
    -53.89 (-0.68%)
     
  • FTSE 250

    19,272.26
    -178.41 (-0.92%)
     
  • AIM

    740.86
    -4.43 (-0.59%)
     
  • GBP/EUR

    1.1683
    -0.0000 (-0.00%)
     
  • GBP/USD

    1.2456
    +0.0018 (+0.14%)
     
  • Bitcoin GBP

    51,909.73
    +2,509.02 (+5.08%)
     
  • CMC Crypto 200

    1,332.23
    +19.60 (+1.52%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • CRUDE OIL

    83.36
    +0.63 (+0.76%)
     
  • GOLD FUTURES

    2,397.20
    -0.80 (-0.03%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,673.62
    -163.78 (-0.92%)
     
  • CAC 40

    7,961.83
    -61.43 (-0.77%)
     

Could Novavax's Next Step Make It a Multibagger?

Could Novavax's Next Step Make It a Multibagger?

Novavax disappointed investors when its regulatory submissions fell behind. Now, all eyes are on Novavax's next step: winning authorization in the U.S. Could this nudge the stock out of its slump -- and even turn it into a multibagger? Novavax reported revenue of $704 million and net income of $203 million.